Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
8.31
-0.09 (-1.07%)
At close: Oct 23, 2026, 4:00 PM EDT
8.24
-0.07 (-0.82%)
After-hours: Oct 23, 2026, 5:31 PM EDT
Contineum Therapeutics Market Cap
Contineum Therapeutics has a market cap or net worth of $312.63 million as of October 23, 2026. It is the 17,801st most valuable company in the world and the 3,142nd biggest in the United States. Its market cap has increased by 1.08% in one year.
Market Cap
312.63M
Enterprise Value
82.65M
1-Year Change
1.08%
Global Rank
Country Rank
#3,142 United States
Category
ChartMarket Cap Chart
Since the IPO on April 5, 2024, Contineum Therapeutics's market cap has decreased from $402.09M to $312.63M, a decrease of -22.25%. That is a compound annual growth rate of -9.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 312.63M | -25.12% |
| Dec 31, 2025 | 417.53M | 10.56% |
| Dec 31, 2024 | 377.64M | -6.08% |
| Apr 5, 2024 | 402.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| YD Bio | 331.49M |
| Nautilus Biotechnology | 329.59M |
| Orchestra BioMed Holdings | 329.38M |
| Atea Pharmaceuticals | 328.04M |
| Opus Genetics | 323.63M |
| X4 Pharmaceuticals | 320.24M |
| Artiva Biotherapeutics | 307.03M |
| Benitec Biopharma | 306.27M |